Prime Medicine Shares Dip on $125 Million Stock Sale
Prime Medicine shares dipped on a $125 million stock sale.
Related stories
Thomson Reuters Plans $500 Million Share Buyback
Thomson Reuters said it plans a $500 million share buyback.
M impact | EQUITY | Nov 11, 2026, 01:01 PM UTC
Modine Stock Rises After Starting Production of Chillers for Data Centers
By Kelly CloonanShares of Modine gained after the company said it started producing Airedale chillers for data center customers.The stock rose 5.9% to $109.16 in premarket trading
L impact | EQUITY | Nov 11, 2026, 12:50 PM UTC
Modine Begins Production at New Grand Prairie Facility
Modine Manufacturing has begun commercial production at its new 682,000-square-foot Grand Prai
M impact | EQUITY | Nov 11, 2026, 12:44 PM UTC
Nasdaq 100 futures extend gains, up 2%
M impact | EQUITY | Nov 11, 2026, 12:41 PM UTC
Bhel Bags Rs 900 Cr Gujarat Renewable Energy Order, Shares Jump Over 3%
The project involves installation of two condensers to support transmission infrastructure associated with renewable energy projects in Jam KhambhaliyaBharat Heavy Electricals (Bhe
L impact | EQUITY | Nov 11, 2026, 12:40 PM UTC
Traders piled back into the artificial intelligence trade, lifting US stock futures following strong results from beaten-down neocloud firm CoreWeave and robust demand for Anthropic's initial public offering.
Traders piled back into the artificial intelligence trade, lifting US stock futures following strong results from beaten-down neocloud firm CoreWeave and robust demand for Anthropi
L impact | EQUITY | Nov 11, 2026, 12:39 PM UTC